CD274 and neoplasm: Taken together, all these results indicated that IFNα-induced PDL1 and PD1 expression may inhibit antitumour immunity and tumour suppression by ICB, and that blocking IFNα signalling could be an effective strategy to enhance the therapeutic efficacy of ICB in HNSCCs.